Hybribio Biotech Subsidiary Secures Medical Device Registration Certificate

Stock News

Mar 04

Guangdong Hybribio Biotech Co.,Ltd. (300639.SZ) announced that its wholly-owned subsidiary, Guangzhou Hybribio Medical Technology Co., Ltd., has obtained a Medical Device Registration Certificate for In Vitro Diagnostic Reagents from the National Medical Products Administration. The certificate was granted for the Chromosome (13/18/21/X/Y) Multiple STR Genotyping Kit (Fluorescent PCR Capillary Electrophoresis Method), which was jointly developed by the subsidiary and the Guangdong Maternal and Child Health Hospital.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1173177117"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1173177117\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1173177117?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 17:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173177117","market":"fut","top_or_hot":-1,"title":"Hybribio Biotech Subsidiary Secures Medical Device Registration Certificate","media":"Stock News","content":"<p>Guangdong Hybribio Biotech Co.,Ltd. (300639.SZ) announced that its wholly-owned subsidiary, Guangzhou Hybribio Medical Technology Co., Ltd., has obtained a Medical Device Registration Certificate for In Vitro Diagnostic Reagents from the National Medical Products Administration. The certificate was granted for the Chromosome (13/18/21/X/Y) Multiple STR Genotyping Kit (Fluorescent PCR Capillary Electrophoresis Method), which was jointly developed by the subsidiary and the Guangdong Maternal and Child Health Hospital.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hybribio Biotech Subsidiary Secures Medical Device Registration Certificate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHybribio Biotech Subsidiary Secures Medical Device Registration Certificate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-04 17:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Guangdong Hybribio Biotech Co.,Ltd. (300639.SZ) announced that its wholly-owned subsidiary, Guangzhou Hybribio Medical Technology Co., Ltd., has obtained a Medical Device Registration Certificate for In Vitro Diagnostic Reagents from the National Medical Products Administration. The certificate was granted for the Chromosome (13/18/21/X/Y) Multiple STR Genotyping Kit (Fluorescent PCR Capillary Electrophoresis Method), which was jointly developed by the subsidiary and the Guangdong Maternal and Child Health Hospital.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1574","symbol_name":"生物医药B类股","start_time":0,"source_url":"","article_id":"1173177117","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173177117","pubTimestamp":1772617573,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Guangdong Hybribio Biotech Co.,Ltd. (300639.SZ) announced that its wholly-owned subsidiary, Guangzhou Hybribio Medical Technology Co., Ltd., has obtained a Medical Device Registration Certificate for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159883":"医疗器械","300639":"凯普生物","BK1574":"生物医药B类股","BK0042":"基因检测","09996":"沛嘉医疗-B","BK1583":"高瓴概念","BK0239":"医药制造","BK0132":"高送转概念","BK0046":"生物疫苗","BK1100":"医疗保健设备","09997":"康基医疗","BK1222":"医疗保健用品"},"translate_title":"Hybribio Biotech子公司获得医疗器械注册证","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159883":1,"300639":1,"09996":1,"09997":1},"content_text":"Guangdong Hybribio Biotech Co.,Ltd. (300639.SZ) announced that its wholly-owned subsidiary, Guangzhou Hybribio Medical Technology Co., Ltd., has obtained a Medical Device Registration Certificate for In Vitro Diagnostic Reagents from the National Medical Products Administration. The certificate was granted for the Chromosome (13/18/21/X/Y) Multiple STR Genotyping Kit (Fluorescent PCR Capillary Electrophoresis Method), which was jointly developed by the subsidiary and the Guangdong Maternal and Child Health Hospital.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}